Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 20 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Sacral resection provides local control of recurrent rectal cancer

Sacrectomy for rectal cancer is a high-risk procedure that can achieve clear resection margins with good local control, and low mortality in select patients, finds August's issue of Diseases of the Colon & Rectum.

News image

fiogf49gjkf04

Composite sacropelvic resection for locally advanced recurrent rectal cancer is a high-risk procedure that benefits select patients.

Dr Genevieve Melton and colleagues from New York reviewed a recent institutional experience to evaluate case selection, morbidity, and outcomes for these patients.

Between 1987 and 2004, 29 patients underwent composite resection for recurrent locoregional rectal cancer.

The research team evaluated clinicopathologic indicators as indicators of survival by log-rank test and Cox proportional hazards model.

The researchers reported that 10 patients received radiotherapy with their previous surgery, 17 before sacrectomy, and 12 received intraoperative therapy.

Sacral resections were performed at S2/S3 or S4/S5 using anterior or combined anterior-posterior approach, with adherence to or cortical invasion in the sacrum.

The researchers found the majority of those who had undergone previous abdominoperineal resection had total exenteration.

Most patients who had undergone a previous sphincter-preserving procedure had abdominoperineal resection and none had exenteration.

The team noted that pedicle flaps were used often.

A median of 5 units of blood was given intraoperatively.

The 2-year recurrence rate was 47%
Diseases of the Colon & Rectum

The researchers observed that transfusions were associated with previous abdominoperineal resection, correlating strongly with postoperative morbidity.

There were 33 complications in 17 patients, most commonly perineal wound breakdown in 9, and pelvic abscess in 5.

Median hospital stay was 18 days, significantly longer in patients with previous abdominoperineal resection or postoperative morbidity.

The team noted that only postoperative death was from pelvic sepsis.

Resection was complete in 18 patients, with microscopically positive margins in 10, and grossly positive margins in 1.

The researchers identified that the 2-year and 5-year recurrence rates were 47% and 85%, respectively.

Disease-specific survival was 63% and 20%, at 2- and 5 years, respectively.

The team found that less transfusion, complete resection, lack of anterior organ involvement, and absence of cortical bone invasion were associated with better survival on univariate analysis.

Original colorectal cancer stage was not associated with improved survival.

Dr Melton's team commented, “Sacrectomy for rectal cancer is a high-risk procedure that can achieve clear resection margins with low mortality in select patients.”

“This procedure has a low cure rate but may provide local disease control with acceptable morbidity.”

Dis Col Rectum 2006: 49(8): 1099-107
17 August 2006

Go to top of page Email this page Email this page to a colleague

 20 February 2018 
Complications and surveillance colonoscopies
 20 February 2018 
Treatment algorithm for polyp cancers
 20 February 2018 
Predictors of postoperative infection in Crohn's
 19 February 2018 
Screening colonoscopy in the right and left colon
 19 February 2018 
NAFLD prevalence in the USA
 19 February 2018 
Fructans in children with IBS

 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Management of hemorrhoids in the USA
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV
 29 January 2018 
Food allergen injections in eosinophilic esophagitis
 29 January 2018 
Reliability of the IBD index
 26 January 2018 
Tofacitinib vs biological therapies for ulcerative colitis
 26 January 2018 
Optimizing selection of biologics in IBD
 26 January 2018 
Nutritional risk and laparoscopic-assisted gastrectomy outcomes
 25 January 2018 
Patient-reported outcome measure for functional dyspepsia
 25 January 2018 
Predicting intra-abdominal infections after colorectal surgery
 25 January 2018 
Predictors of gastric cancer risk
 24 January 2018 
Risk factors underlying previously undiagnosed cirrhosis
 24 January 2018 
Ethnicity influences phenotype in IBD
 24 January 2018 
Bariatric surgery vs medical obesity treatment

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us